Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: II. Glutamate (Ant)agonists.
about
Implications for atypical antipsychotics in the treatment of schizophrenia: neurocognition effects and a neuroprotective hypothesis.Interaction of Memantine with Homocysteine on the Apoptosis in the Rat Hippocampus cells.Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date.
P2860
Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: II. Glutamate (Ant)agonists.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Indirect modulation of dopamin ...... : II. Glutamate (Ant)agonists.
@ast
Indirect modulation of dopamin ...... : II. Glutamate (Ant)agonists.
@en
type
label
Indirect modulation of dopamin ...... : II. Glutamate (Ant)agonists.
@ast
Indirect modulation of dopamin ...... : II. Glutamate (Ant)agonists.
@en
prefLabel
Indirect modulation of dopamin ...... : II. Glutamate (Ant)agonists.
@ast
Indirect modulation of dopamin ...... : II. Glutamate (Ant)agonists.
@en
P2093
P2860
P356
P1476
Indirect modulation of dopamin ...... : II. Glutamate (Ant)agonists.
@en
P2093
P2860
P304
P356
10.1345/APH.19146
P407
P577
2000-06-01T00:00:00Z